Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Blood Pressure Targets and Type 2 Diabetes

Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401–1408

  1. Adam P. Bress1⇑,
  2. Vasilios Papademetriou2 and
  3. Mark N. Feinglos3
  1. 1Division of Health System Innovation and Research, Department of Population Health Sciences, University of Utah, Salt Lake City, UT
  2. 2Washington DC VA Medical Center, Washington, DC
  3. 3Department of Medicine, Duke University School of Medicine, Durham, NC
  1. Corresponding author: Adam P. Bress, adam.bress{at}hsc.utah.edu.
Diabetes Care 2018 Jun; 41(6): e90-e91. https://doi.org/10.2337/dci17-0061
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

We thank Neves et al. (1) for their comments on our article (2). They agree with our findings that results from the Systolic Blood Pressure Intervention Trial (SPRINT) demonstrate that the beneficial effects of intensive systolic blood pressure control are consistent among those with prediabetes and normoglycemia. We found no attenuation of effect of intensive systolic blood pressure control at higher fasting serum glucose levels, including patients with fasting serum glucose levels approaching the diabetic range (i.e., >126 mg/dL) (2). Although this analysis was not a prespecified subgroup analysis in SPRINT, we determined the need for this particular analysis based on considerations external to the SPRINT data. Given the inconsistent results of the overall SPRINT and the Action to Control Cardiovascular Risk in Diabetes Blood Pressure (ACCORD-BP) trials, the question of whether the effect of intensive versus standard systolic blood pressure control was similar among those with fasting normoglycemia and patients with prediabetes and high cardiovascular disease risk became urgent.

We also agree that a better understanding of the association between prediabetes and cardiovascular disease events is needed, particularly among those at high risk for cardiovascular disease. Several meta-analyses of large prospective cohort studies demonstrate a positive and graded association between increasing fasting serum glucose as a continuous variable, beginning as low as 85 mg/dL, and cardiovascular disease events (3–5). Prediabetes as a categorical variable is also associated with an increased risk of cardiovascular disease events. A meta-analysis of 53 prospective cohort studies with 1,611,339 patients found that those with prediabetes (defined by impaired glucose tolerance or impaired fasting glucose according to American Diabetes Association or World Health Organization impaired fasting glucose criteria) had a statistically significant 13% higher risk of cardiovascular disease events over a median follow-up of 9.5 years compared with those with normoglycemia (6). Studies used in these meta-analyses included patients with a wide range of baseline cardiovascular disease risk, making it difficult to understand if the association of prediabetes and cardiovascular disease risk is heterogeneous across a range of baseline cardiovascular disease risk. Examining the association between prediabetes and cardiovascular disease risk in SPRINT was beyond the scope of our analysis, but we do appreciate the analysis by Neves et al. (1). We agree with their conclusions that prediabetes status may not increase cardiovascular risk among patients who are at high risk for cardiovascular disease events. Because prediabetes often coexists with other confounding cardiovascular disease risk factors, such as hypertension, metabolic syndrome, and obesity, it is clear that additional studies are needed that are designed to determine the impact of prediabetes on cardiovascular disease risk in such high-risk populations.

Article Information

Funding. A.P.B. was supported by a grant from the National Heart, Lung, and Blood Institute (1K01HL133468-01).

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Footnotes

  • See accompanying articles, pp. 1132, 1134, 1142, e84, e86, and e88.

  • © 2018 by the American Diabetes Association.
http://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

References

  1. ↵
    1. Neves JS,
    2. Bigotte Vieira M,
    3. Leitão L, et al
    . Comment on Bress et al. Effect of intensive versus standard blood pressure treatment according to baseline prediabetes status: a post hoc analysis of a randomized trial. Diabetes Care 2017;40:1401–1408 (Letter). Diabetes Care 2018;41:e88–e89. DOI: 10.2337/dc17-2311
    OpenUrlFREE Full Text
  2. ↵
    1. Bress AP,
    2. King JB,
    3. Kreider KE, et al.; SPRINT Research Group
    . Effect of intensive versus standard blood pressure treatment according to baseline prediabetes status: a post hoc analysis of a randomized trial. Diabetes Care 2017;40:1401–1408
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Tabák AG,
    2. Herder C,
    3. Rathmann W,
    4. Brunner EJ,
    5. Kivimäki M
    . Prediabetes: a high-risk state for diabetes development. Lancet 2012;379:2279–2290
    OpenUrlCrossRefPubMedWeb of Science
    1. Sarwar N,
    2. Gao P,
    3. Seshasai SR, et al.; Emerging Risk Factors Collaboration
    . Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies [published correction appears in Lancet 2010;376:958]. Lancet 2010;375:2215–2222
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Rao Kondapally Seshasai S,
    2. Kaptoge S,
    3. Thompson A, et al.; Emerging Risk Factors Collaboration
    . Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011;364:829–841
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Huang Y,
    2. Cai X,
    3. Mai W,
    4. Li M,
    5. Hu Y
    . Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ 2016;355:i5953
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Diabetes Care: 41 (6)

In this Issue

June 2018, 41(6)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401–1408
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401–1408
Adam P. Bress, Vasilios Papademetriou, Mark N. Feinglos
Diabetes Care Jun 2018, 41 (6) e90-e91; DOI: 10.2337/dci17-0061

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401–1408
Adam P. Bress, Vasilios Papademetriou, Mark N. Feinglos
Diabetes Care Jun 2018, 41 (6) e90-e91; DOI: 10.2337/dci17-0061
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Article Information
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401–1408
  • Effect of Achieved Systolic Blood Pressure on Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Population-Based Retrospective Cohort Study
Show more Blood Pressure Targets and Type 2 Diabetes

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.